Keith Denkler

Dr. Keith Denkler MD

Clinical Professor of Plastic Surgery, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO


          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Member of the Healthcare Council

Request a consultation with Keith Denkler

Council Member Biography

Keith Denkler, MD, is a Plastic Surgeon in private practice in Marin County, California. Dr. Denkler is board certified in Plastic, Cosmetic and Reconstructive Surgery. He also serves as a Clinical Professor of Plastic Surgery at University of California, San Francisco (UCSF) and is an Attending Surgeon at Moffett/Long Hospitals. Dr. Denkler has specialty training and practice in plastic surgery and hand surgery. He has numerous publications in these areas and his practice is both reconstructive and cosmetic. Dr. Denkler uses products by Allergan, Medicis, Isolagen, Mentor, Johnson and Johnson, Valeant, Cutera laser, Cardinal Health, Henry Schein, and others. He has particular interest and expertise in Dupuytren's contracture and is knowledgeable on Restylane Juvederm and botox, Cutera. (This is me - Update Profile)


Employment History

1996 - Unspecified
Clinical Professor of Plastic Surgery, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
1990 - Unspecified
Plastic Surgeon, Dr. Keith Denkler Private Practice
1989 - 2000
Attending Surgeon, CITY & COUNTY OF SAN FRANCISCO

GLG NewsSM Analyses by Keith Denkler

Opinions and analyses expressed in G+ Insights are solely those of the author. See the Terms of Use for details.


GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Low Recurrence for Dupuytren's after XIAFLEX Treatments

June 15, 2010

Auxilium reports lower recurrence rate on Xiaflex | finance.yahoo.com

Two year followup study of XIAFLEX injections shows an overall recurrence rate of 19%. A comparison to historical controls shows a recurrence rate of 34-39% after surgery, and up to an 85% recurrence rate after needle aponeurotomy.  XIAFLEX compares very well.

Xiaflex will dramatically replace surgery

August 13, 2007

The Journal of Hand Surgery Publishes Initial Phase III Data on Xiaflex (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture | pharmalive.com

The efficacy of Xiaflex to not only open up the bent fingers of Dupuytren's, but its ability to diminish recurrence will dramatically decrease surgery rate for Dupuytren's. 

Strattice™ Opens up the Cosmetic Market

June 20, 2007

Lifecell Corporation receives 510(k) clearance for tissue repair product | www.pipelinereview.com

Alloderm™  is a human donor product. Strattice™ is porcine and using Strattice™ for cosmetic uses opens up new promotional possibilities.

Plasma for Wrinkles: Possbily Effective, but Early

March 14, 2007

Blast Away Wrinkles | www.ivanhoe.com

This technique may have implications as an alternative to lasers or Thermage treatments. Heating tissues with can cause shrinkage, much like meat does on a griddle. The key is heating deeper tissues but not burning the skin or melting the underlying fat.

GLG Study Groups with Keith Denkler(?)

Keith Denkler is not a member of any GLG Study Groups.

View All Study Groups

GLG Live Meetings with Keith Denkler(?)

Keith Denkler has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare